Correlation between BMD and bone scintigraphy in patients with prostate cancer

Urologic Oncology: Seminars and Original Investigations

Volumn 26, Issue 3, 2008, Pages 250-253

  Perk, Hakki ^a   Yildiz, Mustafa ^b   Kosar, Alim ^a   Cerci, Sureyya ^b   Soyupek, Feray ^b   Ozorak, Alper ^a   Dilmen, Cem ^a  

^a School of Medicine   (Turkey)

^b SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Bone metastasis; Bone mineral density; Bone scintigraphy; Prostate cancer

Indexed keywords

ADULT; AGED; ARTICLE; BONE DENSITY; BONE METASTASIS; BONE SCINTISCANNING; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PELVIS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CARCINOMA; TRUNK;

AGED; BONE AND BONES; BONE DENSITY; HUMANS; MALE; PROSTATIC NEOPLASMS; RADIONUCLIDE IMAGING;

EID: 42949120634     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2007.05.027     Document Type: Article

References (17)

1. Landis S.H., Murray T., Bolden S., et al. Cancer statistics. CA Cancer J Clin 49 (1999) 8-31
2. Soloway M.S., Hardeman S.W., Hickey D., et al. Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan. Cancer 61 (1988) 195-202
3. Blake G.M., and Fogelman I. Technical principles of dual energy X-ray absorptiometry. Semin Nuc Med 27 (1997) 210-228
4. Kigami Y., Yamamoto I., Ohnishi H., et al. Relationship between skeletal uptake of 99m Tc-HMDP and bone mineral density in elderly women. Ann Nucl Med 12 (1998) 15-20
5. Franck H., and Munz M. Total body and regional bone mineral densitometry (BMD) and soft tissue measurements: correlations of BMD parameter to lumbar spine and hip. Calcif Tissue Int 67 (2000) 111-115
6. Gotfredsen A., Podenphant J., Nilas L., et al. Discriminative ability of total body bone-mineral measured by dual photon absorptiometry. Scand J Clin Lab Invest 49 (1989) 125-134
7. Kanis J.A. Diagnosis of osteoporosis and assessment of fracture risk. Lancet 359 (2002) 1929-1936
8. Tanaka H., Furukawa Y., Fukunaga K., et al. Bone mineral density for patients with bone metastasis of prostate cancer: A preliminary report. Adv Exp Med Biol 324 (1992) 217-231
9. Hauschka P.V., Mavrakos A.E., Iafrati M.D., et al. Growth factors in bone matrix. Isolation of multiple types of affinity chromatography on heparin sepharose. J Biol Chem 261 (1986) 12665-12674
10. Gutman E.B., Sproul E.E., and Gutman A.B. Significance of increased phosphatase activity of bone at the site of osteoblastic metastases secondary to carcinoma of the prostate gland. Am J Cancer 28 (1998) 485-495
11. Lange P.H., and Vessella R.L. Mechanisms, hypotheses, and questions regarding prostate cancer micrometastases to bone. Cancer Metast Rev 17 (1999) 331-336
12. Galasko C.S. Skeletal metastases. Clin Orthop 210 (1986) 18-30
13. Tofe A.J., Francis M.D., and Harwey W.J. Correlation of neoplasm with incidence and localization of skeletal metastases: An analysis of 1,355 diphosphonate bone scans. J Nucl Med 16 (1975) 986-989
14. Rico H., Chapado M.S., Revilla M., et al. Total and regional bone mass in metastatic cancer of the prostate. Eur Urol 30 (1996) 73-76
15. Sundkvist G.M.G., Nilsson M., Ahlgren L., et al. Relationship between Tc-99m-MDP uptake and bone mineral density in patients with prostatic carcinoma. Nucl Med Commun 12 (1991) 629-636
16. Smith M.R. Diagnosis and management of treatment-related osteoporosis in men with prostate carcinoma. Cancer 97 (2003) 789-795
17. Chang C.H., Tsai C.S., Jim Y.F., et al. Lumbar bone mineral density in prostate cancer patients with bone metastases. Endocr Res 29 (2003) 177-182